Samantha Shi, PharmD, BCOP
Articles by Samantha Shi, PharmD, BCOP

Introducing Tarlatamab-dlle: A New Era in Oncology Treatment
ByAmir Ali, PharmD, BCOP,Phoebe Kim, PharmD Candidate,Stacey Cheung, PharmD Candidate,Samantha Shi, PharmD, BCOP,Harry Shamamian, PharmD, MBA, FACHE,Hien Tang, PharmD, BCOP The therapy offers new hope in solid tumor treatment with fewer adverse effects.

USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ Disease
ByAmir Ali, PharmD, BCOP,Amin Khudari, PharmD Candidate,Vincent Mendiola, MD,George Yaghmour, MD,Samantha Shi, PharmD, BCOP,Hien Tang, PharmD, BCOP,Harry Shamamian, PharmD, MBA, FACHE Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.

Real-World Efficacy, Safety of Tixagevimab/Cilgavimab in Patients With Cancer After EUA Revision
ByAnn Tong, PharmD,Yijun Cai, PharmD Candidate,Samantha Shi, PharmD, BCOP,Hien Tang, PharmD, BCOP,Harry Shamamian, PharmD, MBA, FACHE,Amir Ali, PharmD, BCOP The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.